| Income Statement |
| Total Revenue | 146.04M |
|
| Revenues (USD) | 146.04M |
| Cost of Revenue | 35.53M |
| Gross Profit | 110.51M |
| Operating Expenses | 124.76M |
| Research and Development Expense | 44.14M |
| Selling, General and Administrative Expense | 80.61M |
| Operating Income | -14.25M |
| Interest Expense | 166.00K |
| Income Tax Expense | 1.08M |
| Net Income | -15.49M |
| Net Income Common Stock | -15.49M |
| Net Income Common Stock (USD) | -15.49M |
| Consolidated Income | -15.49M |
| Earnings per Basic Share | -0.20 |
| Earnings per Basic Share (USD) | -0.20 |
| Earnings per Diluted Share | -0.20 |
| Earning Before Interest & Taxes (EBIT) | -14.25M |
| Earning Before Interest & Taxes (USD) | -14.25M |
| Weighted Average Shares | 78.87M |
| Weighted Average Shares Diluted | 78.87M |
| Balance Sheet |
| Cash and Equivalents | 147.02M |
| Cash and Equivalents (USD) | 147.02M |
| Trade and Non-Trade Receivables | 97.09M |
| Current Assets | 275.74M |
| Property, Plant & Equipment Net | 42.67M |
| Total Assets | 709.14M |
| Total Debt | 13.93M |
| Current Liabilities | 360.54M |
| Debt Non-Current | 13.93M |
| Total Liabilities | 388.94M |
| Accumulated Retained Earnings (Deficit) | -792.24M |
| Shareholders Equity | 320.20M |
| Shareholders Equity (USD) | 320.20M |
| Assets Non-Current | 433.40M |
| Total Debt (USD) | 13.93M |
| Deferred Revenue | 281.81M |
| Goodwill and Intangible Assets | 358.29M |
| Liabilities Non-Current | 28.40M |
| Trade and Non-Trade Payables | 17.80M |
| Tax Liabilities | 1.21M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 6.36M |
| Net Cash Flow from Financing | -105.14M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -44.33M |
| Capital Expenditure | -2.62M |
| Issuance (Purchase) of Equity Shares | -98.85M |
| Net Cash Flow from Investing | -2.62M |
| Net Cash Flow from Operations | 63.92M |
| Effect of Exchange Rate Changes on Cash | -489.00K |
| Share Based Compensation | 31.11M |